Neurocrine Biosciences Inc (NASDAQ:NBIX)

72.39
Delayed Data
As of 4:00pm ET
 -3.12 / -4.13%
Today’s Change
71.88
Today|||52-Week Range
119.99
-15.01%
Year-to-Date
No recent news for Neurocrine Biosciences Inc.

Today’s Trading

Previous close75.51
Today’s open74.08
Day’s range72.25 - 78.16
Volume29,657
Average volume (3 months)800,298
Market cap$7.1B
Data as of 4:00pm ET, 01/27/2022

Growth & Valuation

Earnings growth (last year)+983.16%
Earnings growth (this year)-55.21%
Earnings growth (next 5 years)+9.90%
Revenue growth (last year)+32.71%
P/E ratio15.9
Price/Sales8.96
Price/Book6.25

Competitors

 Today’s
change
Today’s
% change
NTLAIntellia Therapeutic...-2.75-3.23%
----
NVAXNovavax Inc-6.25-7.89%
ARWRArrowhead Pharmaceut...-2.33-4.61%
Data as of 4:45pm ET, 01/27/2022

Financials

Next reporting dateFebruary 11, 2022
EPS forecast (this quarter)$0.67
Annual revenue (last year)$1.0B
Annual profit (last year)$407.3M
Net profit margin38.94%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Diego, California

Forecasts